Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10196)
All Articles published online
|
Oct 21, 2005 (publication date) through Dec 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Chen J, Miao L, Li JM, Li YY, Zhu QY, Zhou CL, Fang HQ, Chen HP. Receptor-binding domain of SARS-Cov spike protein: Soluble expression in |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i39/6159.htm |
| Number | Citing Articles |
| 1 |
Maryam Pourhajibagher, Abbas Bahador. Computational Biology Analysis of COVID-19 Receptor-Binding Domains: A Target Site for Indocyanine Green Through Antimicrobial Photodynamic Therapy. Journal of Lasers in Medical Sciences 2020; 11(4): 433 doi: 10.34172/jlms.2020.68
|
| 2 |
Mohd Zulkifli Salleh, Mohd Nor Norazmi, Zakuan Zainy Deris. Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2. PeerJ 2022; 10: e13083 doi: 10.7717/peerj.13083
|
| 3 |
Anthony J. Berndt, Tressa N. Smalley, Bijie Ren, Ryan Simkovsky, Amr Badary, Ashley E. Sproles, Francis J. Fields, Yasin Torres-Tiji, Vanessa Heredia, Stephen P. Mayfield, Andrew Webber. Recombinant production of a functional SARS-CoV-2 spike receptor binding domain in the green algae Chlamydomonas reinhardtii. PLOS ONE 2021; 16(11): e0257089 doi: 10.1371/journal.pone.0257089
|
| 4 |
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, Subhash C. Chauhan, Nikita Tiwari, Somanshi Shukla, Mansi Athalye, Vandana Patravale, Vasso Apostolopoulos, Murali M. Yallapu. Protein subunit vaccines: Promising frontiers against COVID-19. Journal of Controlled Release 2024; 366: 761 doi: 10.1016/j.jconrel.2024.01.017
|
| 5 |
Andrew M. King, Daniel A. Anderson, Emerson Glassey, Thomas H. Segall-Shapiro, Zhengan Zhang, David L. Niquille, Amanda C. Embree, Katelin Pratt, Thomas L. Williams, D. Benjamin Gordon, Christopher A. Voigt. Selection for constrained peptides that bind to a single target protein. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-26350-4
|
| 6 |
Baoning Liu, Siyu Liu, Siyuan Zhang, Liang Bai, Enqi Liu. Bioinformatic evaluation of the potential animal models for studying SARS-Cov-2. Heliyon 2020; 6(12): e05725 doi: 10.1016/j.heliyon.2020.e05725
|
| 7 |
D. V. Grinko, D. V. Moiseev, E. V. Voropaev, I. O. Stoma. Current aspects of COVID-19 vaccine prophylaxis: big steps from laboratory to clinical practice. Health and Ecology Issues 2021; 18(4): 5 doi: 10.51523/2708-6011.2021-18-4-1
|
| 8 |
Yunxia He, Jinming Qi, Lucheng Xiao, Lijuan Shen, Weili Yu, Tao Hu. Purification and characterization of the receptor‐binding domain of SARS‐CoV‐2 spike protein from Escherichia coli. Engineering in Life Sciences 2021; 21(6): 453 doi: 10.1002/elsc.202000106
|
| 9 |
Lena Mahmoudi Azar, Muhammed Miran Öncel, Elif Karaman, Levent Faruk Soysal, Ayesha Fatima, Sy Bing Choi, Alp Ertunga Eyupoglu, Batu Erman, Asif M. Khan, Serdar Uysal. Human ACE2 orthologous peptide sequences show better binding affinity to SARS-CoV-2 RBD domain: Implications for drug design. Computational and Structural Biotechnology Journal 2023; 21: 4096 doi: 10.1016/j.csbj.2023.07.022
|
| 10 |
Marco Spadaccini, Lorenzo Canziani, Alessio Aghemo, Ana Lleo, Roberta Maselli, Andrea Anderloni, Silvia Carrara, Alessandro Fugazza, Gaia Pellegatta, Piera Alessia Galtieri, Cesare Hassan, David Greenwald, Mark Pochapin, Michael Wallace, Prateek Sharma, Thomas Roesch, Pradeep Bhandari, Fabian Emura, Gottumukkala S Raju, Alessandro Repici. What gastroenterologists should know about SARS–CoV 2 vaccine: World Endoscopy Organization perspective. United European Gastroenterology Journal 2021; 9(7): 787 doi: 10.1002/ueg2.12103
|
| 11 |
Mariano Maffei, Linda Celeste Montemiglio, Grazia Vitagliano, Luigi Fedele, Shaila Sellathurai, Federica Bucci, Mirco Compagnone, Valerio Chiarini, Cécile Exertier, Alessia Muzi, Giuseppe Roscilli, Beatrice Vallone, Emanuele Marra. The Nuts and Bolts of SARS-CoV-2 Spike Receptor-Binding Domain Heterologous Expression. Biomolecules 2021; 11(12): 1812 doi: 10.3390/biom11121812
|
| 12 |
Hajarossadat Ghaderi, Alireza Shoari, Shima Salehi, Ayda Hassanzadeh Eskafi, Mahdi Habibi-Anbouhi, Reza Ahangari Cohan, Reza Moazzami, Mahdi Behdani. Expression and purification of SARS-CoV-2 receptor binding domain in Escherichia coli for diagnostic and therapeutic purposes. Research in Pharmaceutical Sciences 2024; 19(5): 500 doi: 10.4103/RPS.RPS_93_23
|
| 13 |
Teodor-D. Brumeanu, Pooja Vir, Ahmad Faisal Karim, Swagata Kar, Dalia Benetiene, Megan Lok, Jack Greenhouse, Tammy Putmon-Taylor, Christopher Kitajewski, Kevin K. Chung, Kathleen P. Pratt, Sofia A. Casares. Human-Immune-System (HIS) humanized mouse model (DRAGA: HLA-A2.HLA-DR4.Rag1KO.IL-2RγcKO.NOD) for COVID-19. Human Vaccines & Immunotherapeutics 2022; 18(5) doi: 10.1080/21645515.2022.2048622
|
| 14 |
Elif Karaman, Serdar Uysal. Aspergillus oryzae as a host for SARS-CoV-2 RBD and NTD expression. Biotech Studies 2024; 33(2): 9 doi: 10.38042/biotechstudies.1497521
|
| 15 |
Lanying Du, Guangyu Zhao, Chris CS Chan, Lin Li, Yuxian He, Yusen Zhou, Bo-Jian Zheng, Shibo Jiang. A 219-mer CHO-Expressing Receptor-Binding Domain of SARS-CoV S Protein Induces Potent Immune Responses and Protective Immunity. Viral Immunology 2010; 23(2): 211 doi: 10.1089/vim.2009.0090
|
| 16 |
Thomas Güttler, Metin Aksu, Antje Dickmanns, Kim M. Stegmann, Kathrin Gregor, Renate Rees, Waltraud Taxer, Oleh Rymarenko, Jürgen Schünemann, Christian Dienemann, Philip Gunkel, Bianka Mussil, Jens Krull, Ulrike Teichmann, Uwe Groß, Volker C Cordes, Matthias Dobbelstein, Dirk Görlich. Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies. The EMBO Journal 2021; 40(19) doi: 10.15252/embj.2021107985
|
| 17 |
Cyrielle Fougeroux, Louise Goksøyr, Manja Idorn, Vladislav Soroka, Sebenzile K. Myeni, Robert Dagil, Christoph M. Janitzek, Max Søgaard, Kara-Lee Aves, Emma W. Horsted, Sayit Mahmut Erdoğan, Tobias Gustavsson, Jerzy Dorosz, Stine Clemmensen, Laurits Fredsgaard, Susan Thrane, Elena E. Vidal-Calvo, Paul Khalifé, Thomas M. Hulen, Swati Choudhary, Michael Theisen, Susheel K. Singh, Asier Garcia-Senosiain, Linda Van Oosten, Gorben Pijlman, Bettina Hierzberger, Tanja Domeyer, Blanka W. Nalewajek, Anette Strøbæk, Magdalena Skrzypczak, Laura F. Andersson, Søren Buus, Anette Stryhn Buus, Jan Pravsgaard Christensen, Tim J. Dalebout, Kasper Iversen, Lene H. Harritshøj, Benjamin Mordmüller, Henrik Ullum, Line S. Reinert, Willem Adriaan de Jongh, Marjolein Kikkert, Søren R. Paludan, Thor G. Theander, Morten A. Nielsen, Ali Salanti, Adam F. Sander. Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity. Nature Communications 2021; 12(1) doi: 10.1038/s41467-020-20251-8
|
| 18 |
Claudia R. Arbeitman, Gabriela Auge, Matías Blaustein, Luis Bredeston, Enrique S. Corapi, Patricio O. Craig, Leandro A. Cossio, Liliana Dain, Cecilia D’Alessio, Fernanda Elias, Natalia B. Fernández, Yamila B. Gándola, Javier Gasulla, Natalia Gorojovsky, Gustavo E. Gudesblat, María G. Herrera, Lorena I. Ibañez, Tommy Idrovo, Matías Iglesias Rando, Laura Kamenetzky, Alejandro D. Nadra, Diego G. Noseda, Carlos H. Paván, María F. Pavan, María F. Pignataro, Ernesto Roman, Lucas A. M. Ruberto, Natalia Rubinstein, Javier Santos, Francisco Velazquez, Alicia M. Zelada. Structural and functional comparison of SARS-CoV-2-spike receptor binding domain produced in Pichia pastoris and mammalian cells. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-78711-6
|
| 19 |
Chong-Hyun Shin, Ki-Hye Kim, Subbiah Jeeva, Sang-Moo Kang. Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome. Cells 2021; 10(6): 1412 doi: 10.3390/cells10061412
|
| 20 |
Zainularifeen Abduljaleel, Sami Melebari, Mohammad Athar, Saied Dehlawi, S. Udhaya Kumar, Syed A. Aziz, Anas Ibrahim Dannoun, Shaheer M. Malik, Jasheela Thasleem, C. George Priya Doss. SARS-CoV-2 vaccine breakthrough infections (VBI) by Omicron variant (B.1.1.529) and consequences in structural and functional impact. Cellular Signalling 2023; 109: 110798 doi: 10.1016/j.cellsig.2023.110798
|
| 21 |
Lanying Du, Guangyu Zhao, Lin Li, Yuxian He, Yusen Zhou, Bo-Jian Zheng, Shibo Jiang. Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells. Biochemical and Biophysical Research Communications 2009; 384(4): 486 doi: 10.1016/j.bbrc.2009.05.003
|
| 22 |
Leandro Núñez-Muñoz, Gabriel Marcelino-Pérez, Berenice Calderón-Pérez, Miriam Pérez-Saldívar, Karla Acosta-Virgen, Hugo González-Conchillos, Brenda Vargas-Hernández, Ana Olivares-Martínez, Roberto Ruiz-Medrano, Daniela Roa-Velázquez, Edgar Morales-Ríos, Jorge Ramos-Flores, Gustavo Torres-Franco, Diana Peláez-González, Jorge Fernández-Hernández, Martha Espinosa-Cantellano, Diana Tapia-Sidas, José Abrahan Ramírez-Pool, América Padilla-Viveros, Beatriz Xoconostle-Cázares. Recombinant Antigens Based on Non-Glycosylated Regions from RBD SARS-CoV-2 as Potential Vaccine Candidates against COVID-19. Vaccines 2021; 9(8): 928 doi: 10.3390/vaccines9080928
|
| 23 |
S. D Bruyakin, D. A Makarevich. STRUCTURAL PROTEINS OF THE SARS-COV-2 CORONAVIRUS: ROLE, IMMUNOGENICITY, SUPERANTIGENIC PROPERTIES AND POTENTIAL USE FOR THERAPEUTIC PURPOSES. Journal of Volgograd State Medical University 2021; 18(2): 18 doi: 10.19163/1994-9480-2021-2(78)-18-27
|
| 24 |
Florian Krammer. SARS-CoV-2 vaccines in development. Nature 2020; 586(7830): 516 doi: 10.1038/s41586-020-2798-3
|
| 25 |
Sohrab Sam, Hamideh Ofoghi, Behrokh Farahmand. Developing of SARS-CoV-2 fusion protein expressed in E. coli Shuffle T7 for enhanced ELISA detection sensitivity – an integrated experimental and bioinformatic approach. Journal of Biomolecular Structure and Dynamics 2024; : 1 doi: 10.1080/07391102.2024.2302941
|
| 26 |
Jingyi Zhao, Jing Chen, Huiyi Wang, Yan Guo, Kai Li, Jidong Liu. Enhanced Thermostability of D-Psicose 3-Epimerase from Clostridium bolteae through Rational Design and Engineering of New Disulfide Bridges. International Journal of Molecular Sciences 2021; 22(18): 10007 doi: 10.3390/ijms221810007
|
| 27 |
Arijit Ghosh, Paritosh K. Kar, Anupam Gautam, Rahul Gupta, Rajveer Singh, Rudra Chakravarti, Velayutham Ravichandiran, Shubhra Ghosh Dastidar, Dipanjan Ghosh, Syamal Roy. An insight into SARS-CoV-2 structure, pathogenesis, target hunting for drug development and vaccine initiatives. RSC Medicinal Chemistry 2022; 13(6): 647 doi: 10.1039/D2MD00009A
|
| 28 |
Maochen Li, Han Wang, Lili Tian, Zehan Pang, Qingkun Yang, Tianqi Huang, Junfen Fan, Lihua Song, Yigang Tong, Huahao Fan. COVID-19 vaccine development: milestones, lessons and prospects. Signal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-00996-y
|
| 29 |
Julieta Sandra CUEVAS-ROMERO, José Luis CERRITEÑO-SÁNCHEZ, Rocío LARA-ROMERO, Marco Antonio VEGA-LÓPEZ, Carmen RAMÍREZ-ESTUDILLO, Humberto RAMÍREZ-MENDOZA, Mikael BERG, Karin LÖVGREN-BENGTSSON. Immunogenicity of a recombinant hemagglutinin neuraminidase-<i>Porcine rubulavirus</i> produced by <i>Escherichia coli</i> of <i>Porcine rubulavirus</i> gives protective immunity of litter after challenge. Journal of Veterinary Medical Science 2022; 84(12): 1595 doi: 10.1292/jvms.22-0207
|